MEDIA RELEASE – ALZHEIMER EUROPE Luxembourg, 17 December 2021 – Today, the European Medicines Agency (EMA), in a decision closely watched by the European dementia community, decided not to authorise aducanumab for the treatment of mild cognitive impairment due to Alzheimer’s disease…
L’Agence européenne des médicaments rejette la demande d’autorisation de mise sur le marché de l’aducanumab
COMMUNIQUÉ DE PRESSE – ALZHEIMER EUROPE Texte traduit de l’anglais Luxembourg, 17 décembre 2021 – Aujourd’hui, l’Agence européenne des médicaments (EMA), dans une décision suivie de près par la communauté européenne de la démence, a décidé de ne pas autoriser l’aducanumab pour le…
Global status report on the public health response to dementia
Source : World Health Organization https://www.who.int/publications/i/item/9789240033245 Halfway into the implementation of the Global dementia action plan, the Global status report on the public health response to dementia takes stock of actions driven by Member States, WHO and civil society since the adoption of…
September : World Alzheimer’s Month
World failing to address dementia challenge 2 September 2021 News release Reading time: 4 min (1026 words)Source : Word Health Organization Only a quarter of countries worldwide have a national policy, strategy or plan for supporting people with dementia and their families, according to…
EMBARGOED: Alzheimer Europe calls for prioritisation of people with dementia and carers in COVID-19 vaccination programmes across Europe
PRESS RELEASE COMMUNIQUE DE PRESSE PRESSEMITTEILUNG Embargoed until: Friday 7 May 2021, 11am CET Alzheimer Europe calls for prioritisation of people with dementia and carers in COVID-19 vaccination programmes across Europe Luxembourg, 7 May 2021 – In a new position…
New global initiative to tackle Alzheimer’s disease
The Davos Alzheimer’s Collaborative aims to build a diverse patient cohort for study, coordinate clinical trials, and improve care. Nayanah Siva reports. To read the report, click on the link below : New global initiative to tackle Alzheimer’s disease …
PRIX SANTKIN 2020
Le Prix Santkin est un prix para-académique offert par la Ligue Nationale Alzheimer Liga sur proposition du jury de l’Académie Royale de Médecine de Belgique. Fondé en 2012, le prix biennal est destiné à couronner et/ou à subventionner la recherche…
N’oublions pas Alzheimer! Bon à tirer du timbre-poste «Le silence d’Alzheimer»
Le 21 août 2020, la Ligue Nationale Alzheimer Liga ASBL/vzw/VoG a chargé Philately & Stamps Printing de l’impression des timbres-poste à édition limitée «Le silence d’Alzheimer». Les ligues régionales, sous la présidence de la Ligue nationale Alzheimer, ont lancé leur…
Rapport d’ADI: “From Plan to Impact III” – Governments must heed the lessons of COVID-19 and the disproportionate impact for people with dementia
Ce rapport est en anglais. Vous pouvez le traduire en français à l’aide de Deepl Translate! London, 25 June 2020 – A new report by ADI calls on world governments to ensure that dementia remains a priority during and after the COVID-19…
WHO 73rd World Health Assembly Statement submitted by Alzheimer’s Disease International
Written statements exceptionally considered under provisional agenda item 3 Address by WHO Director-General devoted to the COVID-19 pandemic response in advance of the opening of the Health Assembly Honourable chair and distinguished delegates, Alzheimer’s Disease International (ADI) is the global…